Genzyme (200 crossing)

Genzyme, a subsidiary of Sanofi, is an R&D-driven biopharmaceutical company focused on utilizing artificial intelligence to enhance healthcare solutions and improve patient outcomes. With a diverse pipeline that includes innovative treatments in immunology, neurology, oncology, and rare diseases, Genzyme is committed to reimagining sustainable healthcare approaches.

Dedicated to advancing scientific breakthroughs, Genzyme actively engages in clinical trials and external innovations to foster collaboration and drive progress in the biopharmaceutical industry. The company emphasizes the importance of diversity, equity, and inclusion within its workforce, reflecting its mission to create a positive impact on the lives of individuals and communities worldwide.

Generated from the website